Vision and Psychosis: A Clinical Translational Perspective

The visual system, as one of the most well understood components of the central nervous system, offers a unique framework for understanding mechanistic aspects of psychosis. In this review, we explore the clinical translational potential of visual system alterations in psychosis spectrum disorders, emphasizing their relevance across neurodevelopmental and neurodegenerative processes. The current evidence supporting the clinical significance of visual alterations is reviewed, covering aspects from the retina to low- and mid-level visual regions of the brain and emphasizing the feasibility, accessibility, and cost-effectiveness of vision science tools. We also discuss the therapeutic promise of visual system assessments for guiding personalized treatments, monitoring responses to novel pharmacological agents, and advancing approaches such as visual remediation and noninvasive brain stimulation to target vision-related symptoms in psychosis spectrum disorders. By addressing current gaps and proposing a roadmap for integrating these tools into psychiatric research and clinical care, this review underscores the significant potential of leveraging the visual system to enhance diagnostic precision and improve clinical outcomes in psychosis spectrum disorders.

Authors

Institutions

Publication Details

Journal
Biological Psychiatry
Published
2025-11-01
DOI
https://doi.org/10.1016/j.biopsych.2025.11.005
Citations
1
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vision and Psychosis: A Clinical Translational Perspective

Steven M. Silverstein, Paulo Lizano, Halide Bilge Türközer, C.A. Tamminga
1 citations
Biological Psychiatry
Schizophrenia research and treatment
1.47
article

Vision and Psychosis: A Clinical Translational Perspective

Steven M. Silverstein, Paulo Lizano, Halide Bilge Türközer, C.A. Tamminga
article en
1 citations

Abstract

The visual system, as one of the most well understood components of the central nervous system, offers a unique framework for understanding mechanistic aspects of psychosis. In this review, we explore the clinical translational potential of visual system alterations in psychosis spectrum disorders, emphasizing their relevance across neurodevelopmental and neurodegenerative processes. The current evidence supporting the clinical significance of visual alterations is reviewed, covering aspects from the retina to low- and mid-level visual regions of the brain and emphasizing the feasibility, accessibility, and cost-effectiveness of vision science tools. We also discuss the therapeutic promise of visual system assessments for guiding personalized treatments, monitoring responses to novel pharmacological agents, and advancing approaches such as visual remediation and noninvasive brain stimulation to target vision-related symptoms in psychosis spectrum disorders. By addressing current gaps and proposing a roadmap for integrating these tools into psychiatric research and clinical care, this review underscores the significant potential of leveraging the visual system to enhance diagnostic precision and improve clinical outcomes in psychosis spectrum disorders.

Biological Psychiatry
McLean Hospital (US), University of Rochester Medical Center (US), Massachusetts General Hospital (US), The University of Texas Southwestern Medical Center (US)
Openalex Percentile: Top 14%
Schizophrenia research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.